CSL has rebranded, bringing together all its business units as a single global company. Under the new architecture, Seqirus will become CSL Seqirus, operating alongside CSL Behring, CSL Plasma and CSL Vifor under the CSL brand.
CSL Seqirus is a central pillar of the company’s long-term future. In a statement Don Lacombe, Director Global Procurement Operations said, “We are excited at the possibilities presented by this new era, as we look to leverage the full global capabilities of CSL and create new pathways for increased collaboration.”
Our commitment to help protect as many people as possible from infectious disease… is as strong as ever
No other changes are anticipated beyond the activation of the new brand identity.
“Our commitment to help protect as many people as possible from infectious disease and to provide a wide range of vaccines, antivenoms and pharmaceutical products for the wellbeing of Australians is as strong as ever,” Mr Lacombe said.
